Physician profile
Jerry Gilbert
NPI 1629079017
$16,006.99
in general payments reported to CMS, 2019-2025
41 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,657 · 2020: $7,266 · 2021: $1,283 · 2022: $1,706 · 2023: $1,758 · 2024: $1,074 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,095.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $7,212.80 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $942.88 | 2019-2024 | Lifevest |
| Abbott Laboratories | $785.79 | 2019-2024 | Gallant, Assurity, Jot Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $781.01 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $689.03 | 2019-2024 | Xarelto |
| Atricure, INC. | $636.97 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $596.75 | 2019-2024 | Eliquis, Camzyos |
| Abiomed | $561.86 | 2019-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $495.23 | 2019 | |
| Amgen INC. | $460.27 | 2019-2024 | Repatha |
| Medtronic, INC. | $333.44 | 2021-2024 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $280.31 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $253.82 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $247.23 | 2019-2024 | Farxiga |
| Pfizer INC. | $241.54 | 2019-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $191.63 | 2022-2023 | Wolverine Coronary Cutting Balloon |
| Novo Nordisk INC | $190.04 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Biosense Webster, INC. | $164.90 | 2022-2023 | Carto 3 |
| Bolton Medical INC | $156.79 | 2023-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Medtronic Vascular, INC. | $99.08 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $80.05 | 2022-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $70.59 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $67.39 | 2022 | |
| Itamar Medical INC | $60.67 | 2022 | |
| Esperion Therapeutics, INC. | $47.22 | 2021-2023 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $46.06 | 2021-2022 | |
| Osprey Medical INC | $30.00 | 2019 | |
| Scpharmaceuticals INC. | $29.22 | 2024 | |
| Teleflex LLC | $29.19 | 2021-2024 | Guardian |
| Kiniksa Pharmaceuticals International, Plc | $29.09 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $21.94 | 2023 | Definity |
| Irhythm Technologies, INC. | $21.57 | 2024 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $21.20 | 2024 | Inspire |
| Medicure Pharma INC. | $20.14 | 2022 | |
| Inari Medical, INC. | $19.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.02 | 2019 | |
| Bardy Diagnostics, INC. | $17.01 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.24 | 2022 | |
| Grifols USA, LLC | $15.60 | 2019 | |
| Vital Connect, INC | $14.72 | 2023 | Vitalpatch Rtm |
| Tactile Systems Technology INC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.